Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E
Author:
- Inès ZidiIZInès Zidi
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 81 (12) , 697-701
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Cellular and Molecular Life Sciences, 2010
- HLA-G and Immune Evasion in Cancer CellsJournal of the Formosan Medical Association, 2010
- Structural basis for NKG2A/CD94 recognition of HLA-EProceedings of the National Academy of Sciences, 2008
- Activation of human monocytes after infection by human coronavirus 229EVirus Research, 2007
- Soluble HLA-G: Are they clinically relevant?Seminars in Cancer Biology, 2007
- Application of Human Leukocyte Antigen–G Expression in the Diagnosis of Human CancerHuman Immunology, 2007
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- The immunotolerance role of HLA-GSeminars in Cancer Biology, 1999
- HLA-G and HLA-C at the feto–maternal interface: lessons learned from pathogenic virusesSeminars in Cancer Biology, 1999
- A Class I Antigen, HLA-G, Expressed in Human TrophoblastsScience, 1990